Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,963 | 390 | 99.5% |
| Education | $27.27 | 3 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $895.41 | 91 | $0 (2024) |
| PFIZER INC. | $597.67 | 54 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $346.45 | 20 | $0 (2024) |
| GlaxoSmithKline, LLC. | $343.28 | 24 | $0 (2024) |
| Lilly USA, LLC | $327.44 | 23 | $0 (2024) |
| ABBVIE INC. | $326.42 | 23 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $195.47 | 15 | $0 (2024) |
| Astellas Pharma US Inc | $189.70 | 12 | $0 (2024) |
| Amgen Inc. | $186.86 | 15 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $181.89 | 13 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $847.20 | 66 | ABBVIE INC. ($270.44) |
| 2023 | $547.23 | 38 | Novo Nordisk Inc ($131.88) |
| 2022 | $290.09 | 26 | Novo Nordisk Inc ($154.21) |
| 2020 | $312.35 | 26 | Novo Nordisk Inc ($132.98) |
| 2019 | $1,319 | 106 | PFIZER INC. ($200.87) |
| 2018 | $1,352 | 108 | PFIZER INC. ($167.44) |
| 2017 | $321.90 | 23 | GlaxoSmithKline, LLC. ($71.05) |
All Payment Transactions
393 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $17.14 | General |
| Category: Biological | ||||||
| 12/17/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $9.74 | General |
| Category: Diabetes | ||||||
| 12/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $13.92 | General |
| Category: NEUROSCIENCE | ||||||
| 12/04/2024 | Boston Scientific Corporation | WATCHMAN Access System (Device) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: WATCHMAN_IC | ||||||
| 12/03/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.96 | General |
| Category: PAIN | ||||||
| 11/27/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $9.41 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $17.94 | General |
| Category: RESPIRATORY | ||||||
| 11/01/2024 | BETA BIONICS, INC. | iLet Bionic Pancreas (Device), iLet Bionic Pancreas, iLet Bionic Pancreas | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Automated insulin delivery system | ||||||
| 10/28/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.26 | General |
| Category: NEUROSCIENCE | ||||||
| 10/24/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: RESPIRATORY | ||||||
| 10/23/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $8.75 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 10/22/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $3.68 | General |
| Category: PAIN | ||||||
| 10/15/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $11.20 | General |
| Category: NEUROSCIENCE | ||||||
| 10/02/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.73 | General |
| Category: NEUROSCIENCE | ||||||
| 10/01/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $8.79 | General |
| Category: Diabetes | ||||||
| 09/25/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $15.92 | General |
| Category: Bone Health | ||||||
| 09/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $3.28 | General |
| Category: NEUROSCIENCE | ||||||
| 09/11/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.43 | General |
| Category: PAIN | ||||||
| 09/11/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $9.53 | General |
| 09/10/2024 | AstraZeneca Pharmaceuticals LP | FLUMIST QUADRIVALENT (Biological) | Food and Beverage | In-kind items and services | $19.30 | General |
| Category: Respiratory | ||||||
| 09/04/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $26.78 | General |
| Category: NEUROSCIENCE | ||||||
| 08/09/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $18.31 | General |
| Category: Diabetes Care | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 83 | 116 | $15,304 | $5,695 |
| 2022 | 3 | 48 | 70 | $7,941 | $2,567 |
| 2021 | 2 | 32 | 59 | $7,433 | $3,024 |
| 2020 | 1 | 22 | 31 | $197.00 | $69.20 |
All Medicare Procedures & Services
11 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 17 | 47 | $11,421 | $4,040 | 35.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 11 | 11 | $2,728 | $1,344 | 49.3% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 20 | 21 | $651.00 | $199.92 | 30.7% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2023 | 12 | 13 | $312.00 | $58.76 | 18.8% |
| 81003 | Automated urinalysis test | Office | 2023 | 23 | 24 | $192.00 | $52.80 | 27.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 13 | 34 | $7,401 | $2,452 | 33.1% |
| 93005 | Routine electrocardiogram (ecg) using at least 12 leads with tracing | Office | 2022 | 19 | 19 | $416.00 | $77.83 | 18.7% |
| 81003 | Automated urinalysis test | Office | 2022 | 16 | 17 | $124.00 | $37.86 | 30.5% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 12 | 36 | $7,272 | $2,972 | 40.9% |
| 81003 | Automated urinalysis test | Office | 2021 | 20 | 23 | $161.00 | $51.75 | 32.1% |
| 81003 | Automated urinalysis test | Office | 2020 | 22 | 31 | $197.00 | $69.20 | 35.1% |
About Dr. Michael Geile, MD
Dr. Michael Geile, MD is a Internal Medicine healthcare provider based in Richmond, Kentucky. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2005. The National Provider Identifier (NPI) number assigned to this provider is 1861499022.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Geile, MD has received a total of $4,990 in payments from pharmaceutical and medical device companies, with $847.20 received in 2024. These payments were reported across 393 transactions from 37 companies. The most common payment nature is "Food and Beverage" ($4,963).
As a Medicare-enrolled provider, Geile has provided services to 185 Medicare beneficiaries, totaling 276 services with total Medicare billing of $11,356. Data is available for 4 years (2020–2023), covering 11 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Richmond, KY
- Active Since 07/02/2005
- Last Updated 12/28/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1861499022
Products in Payments
- Ozempic (Drug) $512.89
- CHANTIX (Drug) $310.71
- SYMBICORT (Drug) $195.02
- VRAYLAR (Drug) $192.33
- XIFAXAN (Drug) $182.76
- Tresiba (Drug) $148.05
- ANORO (Drug) $140.66
- ELIQUIS (Drug) $136.45
- Victoza (Drug) $132.10
- XARELTO (Drug) $130.41
- MYRBETRIQ (Drug) $109.63
- GVOKE HYPOPEN (Drug) $105.64
- JARDIANCE (Drug) $103.12
- Aimovig (Biological) $101.29
- FARXIGA (Drug) $96.65
- EMGALITY (Drug) $96.28
- LYRICA (Drug) $90.97
- JANUVIA (Drug) $88.36
- ENTRESTO (Drug) $86.65
- TRELEGY ELLIPTA (Drug) $84.08
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Richmond
Dr. George Vetrovec, M.d, M.D
Internal Medicine — Payments: $3.2M
Dr. Arun Sanyal, M.d, M.D
Internal Medicine — Payments: $956,666
Dr. Erica Gregonis, Md, MD
Internal Medicine — Payments: $314,689
Dr. Lawrence Schwartz, M.d, M.D
Internal Medicine — Payments: $205,580
Dr. Wally Smith, M.d, M.D
Internal Medicine — Payments: $195,657
Dr. Gaurav Gupta, Md, MD
Internal Medicine — Payments: $189,406